Skip to content

Voyant Health, Ltd.

IsraelFDA 510(k) applicant, unverified

Devices
2

What Voyant Health, Ltd. makes

Voyant Health, Ltd. develops TraumaCad Mobile software, versions 1.0 and 2.0, designed for pre-hospital and emergency medical trauma assessment and decision support.

The company’s portfolio is regulated under FDA 510(k) clearance as Class II devices and is listed in the FDA’s 510(k) database. The company is based in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue2

Newest first, rows 1-2 of 2

Frequently asked questions

How many devices does Voyant Health, Ltd. have in the registry?

The registry currently lists 2 devices for Voyant Health, Ltd.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Voyant Health, Ltd.'s devices?

Among its 2 most recently registered devices, Voyant Health, Ltd. has devices listed in FDA 510(k) (2 devices).

What risk classes do Voyant Health, Ltd.'s devices fall under?

Among its 2 most recently registered devices, the classes recorded for Voyant Health, Ltd.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Voyant Health, Ltd. in the registry?

The most recently registered devices listed for Voyant Health, Ltd. include TraumaCad Mobile Release 1.0 and TraumaCad Mobile Release 2.0.

Generated automatically from registry data and not verified by a human reviewer.